Palle Bekker Jeppesen
Department of Medicine CA-2121
Rigshospitalet
Blegdamsvej 9
DK-2100 Copenhagen
Name/email consistency: high
- Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure. Jeppesen, P.B., Pertkiewicz, M., Messing, B., Iyer, K., Seidner, D.L., O'keefe, S.J., Forbes, A., Heinze, H., Joelsson, B. Gastroenterology (2012)
- Treatment of adult short bowel syndrome patients with teduglutide. Nørholk, L.M., Holst, J.J., Jeppesen, P.B. Expert. Opin. Pharmacother (2012)
- Modern treatment of adult short bowel syndrome patients. Efsen, E., Jeppesen, P.B. Minerva. Gastroenterol. Dietol (2011)
- Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome. Jeppesen, P.B., Gilroy, R., Pertkiewicz, M., Allard, J.P., Messing, B., O'Keefe, S.J. Gut (2011)
- Short bowel patients treated for two years with glucagon-like Peptide 2: effects on intestinal morphology and absorption, renal function, bone and body composition, and muscle function. Jeppesen, P.B., Lund, P., Gottschalck, I.B., Nielsen, H.B., Holst, J.J., Mortensen, J., Poulsen, S.S., Quistorff, B., Mortensen, P.B. Gastroenterol. Res. Pract (2009)
- Growth factors in short-bowel syndrome patients. Jeppesen, P.B. Gastroenterol. Clin. North Am. (2007)
- Glucagon-like peptide-2: update of the recent clinical trials. Jeppesen, P.B. Gastroenterology (2006)
- Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Jeppesen, P.B., Sanguinetti, E.L., Buchman, A., Howard, L., Scolapio, J.S., Ziegler, T.R., Gregory, J., Tappenden, K.A., Holst, J., Mortensen, P.B. Gut (2005)
- Clinical significance of GLP-2 in short-bowel syndrome. Jeppesen, P.B. J. Nutr. (2003)
- Experimental approaches: dietary and hormone therapy. Jeppesen, P.B., Mortensen, P.B. Best. Pract. Res. Clin. Gastroenterol (2003)
- Enhancing bowel adaptation in short bowel syndrome. Jeppesen, P.B., Mortensen, P.B. Curr. Gastroenterol. Rep (2002)
- Effect of high-dose growth hormone and glutamine on body composition, urine creatinine excretion, fatty acid absorption, and essential fatty acids status in short bowel patients: a randomized, double-blind, crossover, placebo-controlled study. Jeppesen, P.B., Szkudlarek, J., Høy, C.E., Mortensen, P.B. Scand. J. Gastroenterol. (2001)
- Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Jeppesen, P.B., Hartmann, B., Thulesen, J., Graff, J., Lohmann, J., Hansen, B.S., Tofteng, F., Poulsen, S.S., Madsen, J.L., Holst, J.J., Mortensen, P.B. Gastroenterology (2001)
- Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon. Jeppesen, P.B., Hartmann, B., Thulesen, J., Hansen, B.S., Holst, J.J., Poulsen, S.S., Mortensen, P.B. Gut (2000)
- Deficiencies of essential fatty acids, vitamin A and E and changes in plasma lipoproteins in patients with reduced fat absorption or intestinal failure. Jeppesen, P.B., Høy, C.E., Mortensen, P.B. Eur. J. Clin. Nutr (2000)
- Differences in essential fatty acid requirements by enteral and parenteral routes of administration in patients with fat malabsorption. Jeppesen, P.B., Høy, C.E., Mortensen, P.B. Am. J. Clin. Nutr. (1999)
- Essential fatty acid deficiency in patients receiving home parenteral nutrition. Jeppesen, P.B., Høy, C.E., Mortensen, P.B. Am. J. Clin. Nutr. (1998)
